Application for Continuing Education Credit

NHIA Member - NHIA Member ID

Non-Member

First Name
Last Name

Type of CE applied for (check all that apply): RPh RN* None

*This CE is no longer availbe for Nurses

License Number License State: Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming

Company:

Address:
City State: Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming Zip:
Phone:
Fax:
Email:
Date Quiz Taken:

Continuing Education Assessment Questions

1. There are only 5 FDA approved indications for IVIG.

2. IgG can be given by IV and SC administration but not IM.

3. IVIG products have been associated with MI and renal failure.

4. The rate of IVIG administration can impact the severity of adverse reactions.

5. Which of the following are considered “expected” reactions to IVIG infusion?

6. Maltose can cause a false positive glucose reading with certain glucometers.

7. Carbohydrate stabilized IVIG products have been most often associated with renal failure.

8. All IVIG products are interchangeable.

9. Patients need to be educated about the specific IVIG product that they are receiving and understand the importance of infusion rate and adverse reactions.

10. Anaphylactoid reactions to IVIG are uncommon, but when they do occur they are thought to be associated with which of the following components of IVIG?

General

1. Is this program used to meet your mandatory CE requirements?

A. Yes
B. No

2. Job description

A. Owner
B. Manager
C. Employee

3. Age Group

A. 21-30
B. 31-40
C. 41-50
D. 51-60
E. Over 60

4. How long have you been practicing as a home infusion clinician?

A. 2 years or less
B. 5 years or less
C. 10 years or less
D. More than 10 years

5. Did this program achieve its stated objectives?

A. Yes
B. No

6. How much of this program can you apply in practice?

A. All
B. Some
C. Very little
D. None

7. How long did it take you to complete both the reading and the quiz?
(minutes)

Objectives

Evaluate the extent to which you have achieved each of these objectives by checking the appropriate number using the following scale:

5 = Excellent
4 = Very well
3 = Average
2 = Partially achieved
1 = Not Achieved

8. Describe the history of IVIG administration and product development.

9. Determine the appropriate course of action when presented with a challenging IgG patient scenario.

10. Explain the four main variables of adverse reactions to IVIG.

11. List and discuss the considerations critical to finding the right match of IVIG product for each patient.

Suggestions for future programs:

Comments:

By checking this box, I am providing my electronic signature confirming the information entered on this certificate is true.